UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

 


 

Date of Report (Date of earliest event reported): July 28, 2005

 

HERBALIFE LTD.

(Exact name of registrant as specified in its charter)

 

Cayman Islands

 

1-32381

 

98-0377871

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(I.R.S. Employer
Identification Number)

 

 

 

 

 

PO Box 309 GT, Ugland House
South Church Street, Grand Cayman
Cayman Islands

(Address of principal executive offices)

 

Registrant’s telephone number, including area code:       c/o (310) 410-9600

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

Item 1.01  Entry into a Material Definitive Agreement.

 

On July 28, 2005 the Board of Directors of Herbalife Ltd. (the “Company”), based on the recommendation of the Compensation Committee, adopted the following changes in compensation for its non-employee directors, effective as of July 29, 2005:

 

1.                                       Increased the annual retainer to $25,000 for its non-independent, non-employee directors.

2.                                       Increased the annual retainer for the Chair of the Audit Committee to $15,000, and increased the annual retainer to $5,000 for the Chair of all other Committees.

3.                                       Increased compensation for attendance at in-person Board meetings to $5,000 per meeting.

4.                                       Increased compensation for attendance at telephonic Board meetings to $1,000 per meeting.

5.                                       Increased compensation for attendance at Board Committee meetings to $2,500 per meeting.

6.                                       Increased the annual equity grant equivalent for Independent Directors to $100,000.  Directors who are employees of the Company are compensated based on negotiated compensation packages.  A summary of the material terms set forth above is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

 

The Board also adopted Recommended Stock Ownership Guidelines for directors.  The recommended level of ownership of Company common shares is five times such Director’s annual retainer, and should be attained within two years of such Director’s appointment to the Board.

 

Item 9.01 Financial Statements and Exhibits

 

(c)                                  Exhibits

 

Exhibit

 

Description

 

 

 

10.1

 

Summary of Non-Employee Director Compensation

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 28, 2005

 

 

 

 

HERBALIFE LTD.

 

 

 

 

 

 

By:

/s/ BRETT R. CHAPMAN

 

 

 

Brett R. Chapman

 

 

General Counsel

 

3



 

EXHIBIT INDEX

 

Exhibit No.

 

Description of Exhibit

 

 

 

10.1

 

Summary of Non-Employee Director Compensation

 

4